PCSC — Freenome, Inc.
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 2017526 ·
Last close
$11.98
Market Cap
$97.68M
52W High
$12.18
52W Low
$11.88
ADV30
39,403
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | — | -941,325 | -114,943 | 85,828,386 | 437,369 | 7,078,077 |
| Mar 2026 | 0 | — | -858,834 | -51,749 | 93,329,160 | 567,179 | 6,305,165 |
| Dec 2025 | 0 | — | -1,675,239 | -740,568 | 92,779,988 | 865,031 | 5,704,244 |
| Sep 2025 | 0 | — | -856,160 | 144,634 | 92,200,869 | 1,177,909 | 4,384,557 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-907,040
Investing CF
$8,158,743
Financing CF
$0
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.07
As of
2026-07-19
Balance + Analyst (yfinance extras)
Retained Earnings
$-6,297,078
Inventory
—
Receivables
$260,910
ST Investments
—
EBIT TTM
$-4,331,558
Pretax Income TTM
$-762,626
Interest Exp TTM
—
Analysts
—
Annual Trend (SEC EDGAR, last 2y)
Revenues vs Net Income (last 2y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -2,980,553 | 837,468 | 92,779,988 | 5,704,244 | — | -864,653 |
| Dec 2024 | — | — | — | 89,899,087 | 3,660,811 | — | — |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| XGN | EXAGEN INC. | $109.44M | $4.53 | — |
| PARK | Park Dental Partners, Inc. | $80.73M | $17.88 | — |
| BNR | Burning Rock Biotech Ltd | $78.44M | $8.90 | — |
| SERA | SERA PROGNOSTICS, INC. | $77.91M | $2.04 | — |
| ALPS | Alps Group Inc | $68.26M | $0.41 | — |
News headlines (Yahoo Finance, 1h cache)
FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.
2026-07-27 12:00 · Yahoo
Freenome Debuts as a Publicly Traded Company Focused on Blood-Based Early Cancer Detection
2026-07-20 20:01 · Yahoo
Cancer Blood Screen SPAC Merger Is Delayed by Test’s Results
2026-07-09 20:48 · Yahoo
Perceptive Capital Solutions Corp Announces Change of Date of Extraordinary General Meeting of Shareholders
2026-07-09 12:00 · Yahoo
Perceptive Capital Solutions Corp and Freenome Announce Effectiveness of Registration Statement for Proposed Business Combination
2026-06-18 20:05 · Yahoo
Top Midday Gainers
2025-12-05 18:12 · Yahoo
Freenome and Perceptive Capital Solutions Corp Announce Business Combination Agreement to Create a Publicly Listed Company Transforming Blood-Based Multi-Cancer Detection through an AI/ML-Enabled Mult
2025-12-05 13:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.